Robert Paris

9.0k total citations
61 papers, 1.3k citations indexed

About

Robert Paris is a scholar working on Virology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Robert Paris has authored 61 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Virology, 22 papers in Infectious Diseases and 21 papers in Epidemiology. Recurrent topics in Robert Paris's work include HIV Research and Treatment (23 papers), HIV/AIDS Research and Interventions (10 papers) and Mosquito-borne diseases and control (6 papers). Robert Paris is often cited by papers focused on HIV Research and Treatment (23 papers), HIV/AIDS Research and Interventions (10 papers) and Mosquito-borne diseases and control (6 papers). Robert Paris collaborates with scholars based in United States, Thailand and Australia. Robert Paris's co-authors include Jérôme H. Kim, Nelson L. Michael, Merlin L. Robb, Mark de Souza, P Thongcharoen, R. J. ROSE, SALLY CHURCH, Sanjay Gurunathan, Punnee Pitisuttithum and Krisada Jongsakul and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Robert Paris

57 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Paris United States 19 564 435 432 334 228 61 1.3k
Renata J.M. Engler United States 21 243 0.4× 303 0.7× 779 1.8× 439 1.3× 283 1.2× 72 2.2k
David Verhoeven United States 17 410 0.7× 706 1.6× 387 0.9× 520 1.6× 222 1.0× 34 1.4k
Sean Philpott United States 18 739 1.3× 350 0.8× 667 1.5× 208 0.6× 181 0.8× 39 1.3k
Lindi Masson South Africa 23 293 0.5× 490 1.1× 362 0.8× 584 1.7× 216 0.9× 48 1.6k
David C. Wright United States 10 448 0.8× 248 0.6× 269 0.6× 374 1.1× 153 0.7× 15 985
Frances K. Newman United States 27 836 1.5× 1.2k 2.6× 705 1.6× 1.5k 4.5× 827 3.6× 43 2.8k
Janine Maenza United States 24 1.0k 1.8× 336 0.8× 1.1k 2.4× 537 1.6× 224 1.0× 37 1.6k
Sanja Huibner Canada 20 558 1.0× 562 1.3× 417 1.0× 611 1.8× 235 1.0× 49 1.7k
Tracy Rourke United States 17 1.1k 1.9× 889 2.0× 499 1.2× 477 1.4× 110 0.5× 18 1.6k
Elizabeth S. Machado Brazil 21 508 0.9× 309 0.7× 660 1.5× 388 1.2× 111 0.5× 65 1.3k

Countries citing papers authored by Robert Paris

Since Specialization
Citations

This map shows the geographic impact of Robert Paris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Paris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Paris more than expected).

Fields of papers citing papers by Robert Paris

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Paris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Paris. The network helps show where Robert Paris may publish in the future.

Co-authorship network of co-authors of Robert Paris

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Paris. A scholar is included among the top collaborators of Robert Paris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Paris. Robert Paris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fierro, Carlos, et al.. (2025). Shared clinical and immunologic features of mRNA vaccines: preliminary results from a comparative clinical study. Frontiers in Immunology. 16. 1501275–1501275.
2.
McManus, Margaret, Qixin Wang, Wonyeong Jung, et al.. (2025). Acute infectious mononucleosis generates persistent, functional EBNA-1 antibodies with high cross-reactivity to alpha-crystalline beta. Cell Reports. 44(5). 115709–115709. 1 indexed citations
3.
Spergel, Amanda K. Rudman, Ivan T. Lee, Andrei Avanesov, et al.. (2025). Immunogenicity and safety of mRNA-based seasonal influenza vaccines encoding hemagglutinin and neuraminidase. Nature Communications. 16(1). 5933–5933. 3 indexed citations
4.
Alsdurf, Hannah, Vanesa Bol, Nathalie De Schrevel, et al.. (2024). Establishing Correlates of Maternal-Fetal Cytomegalovirus Transmission—One Step Closer Through Predictive Modeling. The Journal of Infectious Diseases. 230(6). e1274–e1286. 1 indexed citations
5.
Ananworanich, Jintanat, Ivan T. Lee, Andrei Avanesov, et al.. (2024). Safety and Immunogenicity of mRNA-1010, an Investigational Seasonal Influenza Vaccine, in Healthy Adults: Final Results From a Phase 1/2 Randomized Trial. The Journal of Infectious Diseases. 231(1). e113–e122. 23 indexed citations
6.
Paris, Robert. (2023). SARS-CoV-2 Infection and Response to COVID-19 Vaccination in Patients With Primary Immunodeficiencies. The Journal of Infectious Diseases. 228(Supplement_1). S24–S33. 9 indexed citations
7.
Paris, Robert, Dan Apter, Suresh B. Boppana, et al.. (2023). Incidence of Cytomegalovirus Primary and Secondary Infection in Adolescent Girls: Results From a Prospective Study. The Journal of Infectious Diseases. 228(11). 1491–1495. 4 indexed citations
8.
Friberg, Heather, Amanda M. Kong, Leyi Lin, et al.. (2022). Characterization of B-cell and T-cell responses to a tetravalent dengue purified inactivated vaccine in healthy adults. npj Vaccines. 7(1). 132–132. 7 indexed citations
9.
Ratto‐Kim, Silvia, et al.. (2018). The US Military Commitment to Vaccine Development: A Century of Successes and Challenges. Frontiers in Immunology. 9. 1397–1397. 19 indexed citations
10.
Paris, Robert, Lucimar G. Milagres, Eirini Moysi, et al.. (2017). Lower Baseline Germinal Center Activity and Preserved Th1 Immunity are Associated with Hepatitis B Vaccine Response in Treated HIV Infection. SHILAP Revista de lepidopterología. 2(1). 66–66. 10 indexed citations
11.
Gandhi, Rajesh T., Ronald J. Bosch, Ram Rangsin, et al.. (2015). HLA Class I Alleles Associated with Mortality in Thai Military Recruits with HIV-1 CRF01_AE Infection. AIDS Research and Human Retroviruses. 32(1). 44–49. 6 indexed citations
12.
Paris, Robert, Robert A. Kuschner, Leonard N. Binn, et al.. (2014). Adenovirus Type 4 and 7 Vaccination or Adenovirus Type 4 Respiratory Infection Elicits Minimal Cross-Reactive Antibody Responses to Nonhuman Adenovirus Vaccine Vectors. Clinical and Vaccine Immunology. 21(5). 783–786. 14 indexed citations
13.
Arroyo, Miguel A., Nittaya Phanuphak, Sunee Sirivichayakul, et al.. (2010). HIV Type 1 Molecular Epidemiology among High-Risk Clients Attending the Thai Red Cross Anonymous Clinic in Bangkok, Thailand. AIDS Research and Human Retroviruses. 26(1). 5–12. 26 indexed citations
14.
Currier, Jeffrey R., Viseth Ngauy, Mark de Souza, et al.. (2010). Phase I Safety and Immunogenicity Evaluation of MVA-CMDR, a Multigenic, Recombinant Modified Vaccinia Ankara-HIV-1 Vaccine Candidate. PLoS ONE. 5(11). e13983–e13983. 62 indexed citations
15.
Ananworanich, Jintanat, Nittaya Phanuphak, Mark de Souza, et al.. (2008). Incidence and Characterization of Acute HIV-1 Infection in a High-Risk Thai Population. JAIDS Journal of Acquired Immune Deficiency Syndromes. 49(2). 151–155. 43 indexed citations
16.
Ratto‐Kim, Silvia, Thippawan Chuenchitra, Lynn Pulliam, et al.. (2008). Expression of monocyte markers in HIV-1 infected individuals with or without HIV associated dementia and normal controls in Bangkok Thailand. Journal of Neuroimmunology. 195(1-2). 100–107. 6 indexed citations
17.
Thongcharoen, P, Vinai Suriyanon, Robert Paris, et al.. (2007). A Phase 1/2 Comparative Vaccine Trial of the Safety and Immunogenicity of a CRF01_AE (Subtype E) Candidate Vaccine. JAIDS Journal of Acquired Immune Deficiency Syndromes. 46(1). 48–55. 67 indexed citations
18.
Ratto‐Kim, Silvia, Robin P. Garner, Jérôme H. Kim, et al.. (2004). Prospective Analyses of HIV‐1–Specific Proliferative Responses, Recall Antigen Proliferative Responses, and Clinical Outcomes in an HIV‐1–Seropositive Cohort. The Journal of Infectious Diseases. 189(11). 1988–1995. 6 indexed citations
19.
Stewart, G. A. & Robert Paris. (1962). SULPHAMETHOXYPYRIDAZINE BLOOD LEVELS IN HORSES, DOGS, SHEEP AND CATTLE FOLLOWING ORAL ADMINISTRATION. Australian Veterinary Journal. 38(11). 535–541. 3 indexed citations
20.
Paris, Robert, et al.. (1953). [The antibiotic power of cepharanthin in tuberculosis].. PubMed. 29(19). 970–4.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Renata J.M. Engler Breakdown of academic impact, for papers by David Verhoeven Breakdown of academic impact, for papers by Sean Philpott Breakdown of academic impact, for papers by Lindi Masson Breakdown of academic impact, for papers by David C. Wright Breakdown of academic impact, for papers by Frances K. Newman Breakdown of academic impact, for papers by Janine Maenza Breakdown of academic impact, for papers by Sanja Huibner Breakdown of academic impact, for papers by Tracy Rourke Breakdown of academic impact, for papers by Elizabeth S. Machado
Rankless by CCL
2026